Skip to content

Shares (Basic) at other companies

Amgen logo
AmgenAMGN
540M+0.4%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
24.7M+75.9%
Glaukos logo
GlaukosGKOS
58M+2.4%
EyePoint, Inc.
 logo
EyePoint, Inc. EYPT
86M+23.3%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
224.1M+32.3%
Kodiak Sciences Inc logo
Kodiak Sciences IncKOD
61.9M+17.3%

Other financials

Income statement

See full
Revenue$3.6B+19.0%
Operating income$642.9M+8.7%
Net income$727.2M-10.1%
EPS (diluted)$6.75-7.2%

Balance sheet

See full
Cash & equivalents$3.0B-4.0%
Total debt$2.7B+0.1%
Total equity$31.4B+6.9%
Total assets$40.9B+8.9%

Cash flow

See full
Operating cash flow$1.1B+3.2%
CapEx$230.6M+0.6%
Free cash flow$848.3M+4.0%

Valuation

See full
Market cap$65.37B+21.9%
Enterprise value$65.11B+20.0%
P/E14.8×+2.8×
P/S4.4×+0.6×

Profitability

See full
Gross margin93.9%
Operating margin24.3%-2.9pp
Net margin29.6%-2.3pp
FCF margin27.6%+5.5pp

Returns & leverage

See full
Return on equity14.5%-1.4pp
Debt / equity0.1×0.0×
Current ratio3.6×-1.4×

Where this comes from

Reported directly by Regeneron Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.

The official record: Regeneron Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Regeneron Pharmaceuticals's shares (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Regeneron Pharmaceuticals's shares (basic)?
Regeneron Pharmaceuticals (REGN) reported shares (basic) of 104M in Q1 2026.
How has Regeneron Pharmaceuticals's shares (basic) changed year-over-year?
Regeneron Pharmaceuticals's shares (basic) decreased by 2.5% year-over-year, from 106.7M to 104M.
What is the long-term trend for Regeneron Pharmaceuticals's shares (basic)?
Over 4 years (2021 to 2025), Regeneron Pharmaceuticals's shares (basic) has grown at a -0.1% compound annual growth rate (CAGR), from 422.3M to 420M.
What does shares (basic) mean?
The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.